Quarterly report pursuant to Section 13 or 15(d)

Supplemental Cash Flow Information Disclosure: Schedule of Cash Flow, Supplemental Disclosures (Details)

v2.4.0.8
Supplemental Cash Flow Information Disclosure: Schedule of Cash Flow, Supplemental Disclosures (Details) (USD $)
6 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Details    
Cash paid for interest $ 152,813 $ 49,643
Cash paid for income taxes   100
Series C Dividend payable in accounts payable 17,870 47,591
Series D Dividend payable in accrued expenses 49,237  
Beneficial conversion feature on warrants issued in conjunction with Series D preferred shares 24,279  
Shares issued in acquisition of Dr. Pave $ 175,000